What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Diabetes mellitus
Santica M. Marcovina mostly deals with Internal medicine, Endocrinology, Diabetes mellitus, Lipoprotein and Lipoprotein.
The study of Internal medicine is intertwined with the study of Placebo in a number of ways.
Santica M. Marcovina combines topics linked to Coronary artery disease with her work on Endocrinology.
The study incorporates disciplines such as Body mass index and Incidence in addition to Diabetes mellitus.
Her Lipoprotein study incorporates themes from Cardiology, Apolipoprotein E, Pathogenesis and Apolipoprotein B.
Her study in Lipoprotein is interdisciplinary in nature, drawing from both Stroke, Relative risk, Prospective cohort study and Intensive care medicine.
Her most cited work include:
- Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial (2087 citations)
- Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. (1021 citations)
- Incidence of diabetes in youth in the United States. (799 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Internal medicine, Endocrinology, Diabetes mellitus, Lipoprotein and Lipoprotein.
Her research integrates issues of Placebo and Cardiology in her study of Internal medicine.
As part of her studies on Endocrinology, Santica M. Marcovina often connects relevant areas like Apolipoprotein E.
The Diabetes mellitus study combines topics in areas such as Young adult and Research design.
In Lipoprotein, she works on issues like Apolipoprotein B, which are connected to Chromatography, Gene isoform and Monoclonal antibody.
Her studies deal with areas such as Gastroenterology, Vascular disease and PCSK9 as well as Lipoprotein.
She most often published in these fields:
- Internal medicine (65.71%)
- Endocrinology (49.12%)
- Diabetes mellitus (34.07%)
What were the highlights of her more recent work (between 2016-2021)?
- Internal medicine (65.71%)
- Diabetes mellitus (34.07%)
- Type 1 diabetes (19.03%)
In recent papers she was focusing on the following fields of study:
Santica M. Marcovina mainly investigates Internal medicine, Diabetes mellitus, Type 1 diabetes, Endocrinology and Type 2 diabetes.
Her work deals with themes such as Placebo and Cardiology, which intersect with Internal medicine.
Her Diabetes mellitus study combines topics in areas such as Young adult and Arterial stiffness.
Her Type 1 diabetes research focuses on Disease and how it connects with Bioinformatics and Epidemiology.
Many of her studies involve connections with topics such as Efflux and Endocrinology.
Her Type 2 diabetes research is multidisciplinary, incorporating perspectives in Body mass index, Nephropathy, Blood pressure, Public health and Type 2 Diabetes Mellitus.
Between 2016 and 2021, her most popular works were:
- Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012 (689 citations)
- Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood. (243 citations)
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. (170 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Diabetes mellitus
Santica M. Marcovina spends much of her time researching Internal medicine, Lipoprotein, Diabetes mellitus, Lipoprotein and Endocrinology.
Her study in Glycemic, Body mass index, Cholesterol, Odds ratio and Myocardial infarction are all subfields of Internal medicine.
She interconnects Cardiology, Placebo, Metabolic syndrome and Apolipoprotein B in the investigation of issues within Lipoprotein.
As a part of the same scientific family, Santica M. Marcovina mostly works in the field of Diabetes mellitus, focusing on Cohort study and, on occasion, Area under the curve and Blood pressure.
Her research investigates the connection between Lipoprotein and topics such as PCSK9 that intersect with problems in Kexin and Alirocumab.
Her Type 2 diabetes study deals with Type 2 Diabetes Mellitus intersecting with Insulin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
